Actively Recruiting
The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies
Led by Seattle Children's Hospital · Updated on 2026-04-30
116
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study explores the use of an exclusive human milk diet versus standard feeding practices to compare the influence on feeding outcomes and the gut bacteria in infants with intestinal differences.
CONDITIONS
Official Title
The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Infants diagnosed with gastroschisis, giant omphalocele, intestinal atresia, mid-gut volvulus, or Hirschsprung disease
You will not qualify if you...
- Infant has already started feeds
- Infants born before 34 weeks gestation
- Parents with contraindications to providing milk, including drug use with cocaine, fentanyl, or methamphetamine (oxycodone, suboxone, and marijuana are allowed)
- Presence of complicated gastroschisis
- Diagnosis of short gut syndrome
- Additional congenital anomalies that affect milk tolerance, such as cyanotic congenital heart disease (kidney disease is allowed)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seattle Children's Hospital
Seattle, Washington, United States, 98105
Actively Recruiting
Research Team
L
Leonel Arellano
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here